The pharmaceutical unit dose packaging market is expected to experience a change in its operations, as manufacturers are focusing towards increasing productivity through integration of automation systems, as per a study by Future Market Insights (FMI). According to the report, the market will surpass US$ 26.10 Bn by 2021, registering a double-digit year-on-year (Y-o-Y) growth between 2020 and 2021.
Unit dose packaging is a type of primary packaging, which constitutes the first level of containers used for packaging of pharmaceutical products. These include blisters, vials, ampoules, and prefilled syringes cartridges.
The increasing use of medications as a part of treatment prescribed for various ailments and for large vaccination programs undertaken by leading international organizations such as UNISEF, the World Health Organization (WHO), and others have been significantly fuelling the demand for pharmaceutical unit dose packaging solutions. Sales have been skyrocketing amid vaccination drives and treatment offered to contain COVID-19.
Download A Sample this Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-5236
Country-wise Insights
Sound Pharmaceutical Base Supports Growth in U.S.
According to the report, the United States is likely to exhibit consistent demand for pharmaceutical unit dose packaging products over the next five years. One of the key aspects supporting market growth is that, the U.S. is the place for most of the top pharmaceutical drugs & medications research and development and manufacturing facilities who specifically deal with new product developments for various diseases.
Johnson & Johnson, Pfizer Inc., AbbVie Inc., Eli Lilly and Company, and many others have their R&D and manufacturing facilities in the U.S. which plays an important role in fuelling sales of pharmaceutical unit dose packaging solutions.
On the other hand, the top suppliers of pharmaceutical unit dose packaging products such as West Pharmaceutical Services, Inc., Berry Global, Inc., Aptar Group, Inc., Becton, Dickinson & Company, and Catalent, Inc. are tirelessly supplying their services to the customers in the U.S.
Key Takeaways from Pharmaceutical Unit Dose Packaging Market
- Pharmaceutical unit dose packaging sales will surge at 14.7% CAGR between 2021 and 2031
- The presence of several leading players has enabled the U.S. account for over 87% of sales in North America in 2021
- Rising research and development initiatives enabling the U.K. exhibit over 15% y-o-y growth in 2021
- Surging healthcare spending has been fuelling the demand in Germany and France
- Increasing demand for vaccination amid COVID-19 fuelling sales in China, Japan, and South Korea
Competitive Landscape
(Global Players)
- Gerresheimer AG
- West Pharmaceutical Services, Inc.
- Schott AG
- SGD SA
- Stevanato Group S.p.a.
- Klockner Pentaplast Group
- UDG Healthcare plc
- Amcor plc
- Berry Global, Inc.
- Comar LLC
- Constantia Flexibles Group GmbH
- Nipro Corporation
- Catalent, Inc.
- Becton, Dickinson and Company
Get Customization in the Report, Enquire Now @
https://www.futuremarketinsights.com/customization-available/rep-gb-5236
Covid-19 Scenario:
Multi-dose packaging must ensure fewer “touchpoints” for the processing of a patient’s prescriptions during the COVID-19 outbreak, while avoiding the uncertainty that occurs with self-medicating. In addition to the regular illnesses’ precautions and treatments, the need for pharmaceutical unit dose packaging is forecast to rise with the global roll-out of COVID-19 treatment programs. Over the COVID-19 era, the demand for pharmaceuticals and medical items has increased, leading in an increase in blister packaging demand.
New hospitals and COVID-19 centers are springing up all around the world as the number of COVID-19 patients rises, increasing the demand for medical treatment. Unit dosage packaging helps existing and post-COVID healthcare delivery operations by minimizing the risk of handling and pouring liquid doses from the same bottle. Furthermore, a surge in demand for unit dose packing in vials has occurred from the increased demand for the COVID-19 vaccine, as well as the government’s large number of immunizations programs.
Pharmaceutical unit dose packaging Market by Category
Product:
- Blisters Pharmaceutical Unit Dose Packaging
- Ampoules Pharmaceutical Unit Dose Packaging
- Vials Pharmaceutical Unit Dose Packaging
- Prefilled Syringes Cartridges
Material:
- Plastic Pharmaceutical Unit Dose Packaging
- Polyethylene(PE)
- High Density Polyethylene (HDPE)
- Low Density Polyethylene (LDPE)
- Polypropylene Pharmaceutical Unit Dose Packaging
- Poly vinyl chloride(PVC) Pharmaceutical Unit Dose Packaging
- Polyethylene Terephthalate (PET) Pharmaceutical Unit Dose Packaging
- Polyethylene(PE)
- Aluminum Pharmaceutical Unit Dose Packaging
- Glass Pharmaceutical Unit Dose Packaging
- Paper & Paperboard Pharmaceutical Unit Dose Packaging
About Us
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights Inc.
Christiana Corporate,
200 Continental Drive,
Suite 401, Newark,
Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs